Literature DB >> 27562619

Human carbonyl reductase 1 as efficient catalyst for the reduction of glutathionylated aldehydes derived from lipid peroxidation.

Rossella Rotondo1, Roberta Moschini1, Giovanni Renzone2, Tiziano Tuccinardi3, Francesco Balestri1, Mario Cappiello1, Andrea Scaloni2, Umberto Mura1, Antonella Del-Corso4.   

Abstract

Human recombinant carbonyl reductase 1 (E.C. 1.1.1.184, hCBR1) is shown to efficiently act as aldehyde reductase on glutathionylated alkanals, namely 3-glutathionyl-4-hydroxynonanal (GSHNE), 3-glutathionyl-nonanal, 3-glutathionyl-hexanal and 3-glutathionyl-propanal. The presence of the glutathionyl moiety appears as a necessary requirement for the susceptibility of these compounds to the NADPH-dependent reduction by hCBR1. In fact the corresponding alkanals and alkenals, and the cysteinyl and γ-glutamyl-cysteinyl alkanals adducts were either ineffective or very poorly active as CBR1 substrates. Mass spectrometry analysis reveals the ability of hCBR1 to reduce GSHNE to the corresponding GS-dihydroxynonane (GSDHN) and at the same time to catalyze the oxidation of the hemiacetal form of GSHNE, generating the 3-glutathionylnonanoic-δ-lactone. These data are indicative of the ability of the enzyme to catalyze a disproportion reaction of the substrate through the redox recycle of the pyridine cofactor. A rationale for the observed preferential activity of hCBR1 on different GSHNE diastereoisomers is given by molecular modelling. These results evidence the potential of hCBR1 acting on GSHNE to accomplish a dual role, both in terms of HNE detoxification and, through the production of GSDHN, in terms of involvement into the signalling cascade of the cellular inflammatory response.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-glutathionyl-4-hydroxynonanal; 4-hydroxy-2-nonenal; Carbonyl reductase 1; Hydroxynonenal detoxification

Mesh:

Substances:

Year:  2016        PMID: 27562619     DOI: 10.1016/j.freeradbiomed.2016.08.015

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

1.  Reactivity-Based Probe of the Iron(II)-Dependent Interactome Identifies New Cellular Modulators of Ferroptosis.

Authors:  Ying-Chu Chen; Juan A Oses-Prieto; Lauren E Pope; Alma L Burlingame; Scott J Dixon; Adam R Renslo
Journal:  J Am Chem Soc       Date:  2020-10-30       Impact factor: 15.419

2.  Carbonyl Reductase 1 Attenuates Ischemic Brain Injury by Reducing Oxidative Stress and Neuroinflammation.

Authors:  Leilei Mao; Kun Wang; Pengjie Zhang; Shihao Ren; Jingyi Sun; Mingfeng Yang; Feng Zhang; Baoliang Sun
Journal:  Transl Stroke Res       Date:  2021-05-08       Impact factor: 6.829

3.  The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.

Authors:  Jan Moritz Seliger; Livia Misuri; Edmund Maser; Jan Hintzpeter
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

4.  Pathways of 4-Hydroxy-2-Nonenal Detoxification in a Human Astrocytoma Cell Line.

Authors:  Eleonora Peroni; Viola Scali; Francesco Balestri; Mario Cappiello; Umberto Mura; Antonella Del Corso; Roberta Moschini
Journal:  Antioxidants (Basel)       Date:  2020-05-05

5.  Aldose Reductase Differential Inhibitors in Green Tea.

Authors:  Francesco Balestri; Giulio Poli; Carlotta Pineschi; Roberta Moschini; Mario Cappiello; Umberto Mura; Tiziano Tuccinardi; Antonella Del Corso
Journal:  Biomolecules       Date:  2020-07-06

6.  Upregulation of Carbonyl Reductase 1 by Nrf2 as a Potential Therapeutic Intervention for Ischemia/ Reperfusion Injury during Liver Transplantation.

Authors:  Jae Hyun Kwon; Jooyoung Lee; Jiye Kim; Varvara A Kirchner; Yong Hwa Jo; Takeshi Miura; Nayoung Kim; Gi-Won Song; Shin Hwang; Sung-Gyu Lee; Young-In Yoon; Eunyoung Tak
Journal:  Mol Cells       Date:  2019-09-30       Impact factor: 5.034

7.  Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Lisa Ma; Anthony W Herren; Glenda Espinal; Jamie Randol; Bridget McLaughlin; Veronica Martinez-Cerdeño; Isaac N Pessah; Randi J Hagerman; Paul J Hagerman
Journal:  Acta Neuropathol Commun       Date:  2019-09-03       Impact factor: 7.801

Review 8.  Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential.

Authors:  Reza Khayami; Seyyed Reza Hashemi; Mohammad Amin Kerachian
Journal:  J Cell Mol Med       Date:  2020-07-06       Impact factor: 5.310

9.  The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase.

Authors:  Livia Misuri; Mario Cappiello; Francesco Balestri; Roberta Moschini; Vito Barracco; Umberto Mura; Antonella Del-Corso
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

10.  Stereoselectivity of Aldose Reductase in the Reduction of Glutathionyl-Hydroxynonanal Adduct.

Authors:  Francesco Balestri; Vito Barracco; Giovanni Renzone; Tiziano Tuccinardi; Christian Silvio Pomelli; Mario Cappiello; Marco Lessi; Rossella Rotondo; Fabio Bellina; Andrea Scaloni; Umberto Mura; Antonella Del Corso; Roberta Moschini
Journal:  Antioxidants (Basel)       Date:  2019-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.